PULSE YOUR HEALTH

Welcome to Pulse Your Health, the blog where we explore everything related to health and wellness. Today, we’re diving into a groundbreaking new drug making headlines: Zepbound. Zepbound is a product developed by Eli Lilly and Company, a pharmaceutical leader specializing in treatments for diabetes, obesity, and other metabolic disorders. Recently approved by the FDA, Zepbound offers new hope for managing obesity and type 2 diabetes—two conditions that affect millions worldwide. What is Zepbound? Zepbound is a GIP and GLP-1 receptor agonist, which means it mimics the action of two important hormones—GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). These hormones regulate appetite and glucose metabolism. By activating these receptors, Zepbound helps people with obesity and diabetes manage their weight and blood sugar levels more effectively. Why is Zepbound FDA Approval Significant? The FDA’s approval of Zepbound is a major milestone in the fight a...